You have 9 free searches left this month | for more free features.

CLASSIC II

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)

Not yet recruiting
  • Kaposi Sarcoma
  • +2 more
  • Pembrolizumab + Lenvatinib
  • (no location specified)
Apr 27, 2023

Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Concurrent penpulimab and AVD
  • Sequential penpulimab and AVD
  • (no location specified)
Jul 10, 2023

Fabry Disease Trial in China (AL01211)

Recruiting
  • Fabry Disease
  • Guangzhou, Guangdong, China
  • +5 more
Nov 2, 2023

Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular

Recruiting
  • Ann Arbor Stage I Hodgkin Lymphoma
  • +13 more
  • Birmingham, Alabama
  • +16 more
Nov 23, 2021

Primary Teeth Trial in Isparta (Dyract XP (Dentsply De Trey), Kerr Herculite Classic (Kerr Corporation),R&D Series NOVA(Kuraray

Completed
  • Primary Teeth
  • Dyract XP (Dentsply De Trey), Kerr Herculite Classic (Kerr Corporation),R&D Series NOVA(Kuraray Medical Inc) Clearfil TM SE Bond (Kuraray Medical),Hydrocal LC (Medicept Dental)
  • Isparta, Turkey
    Suleyman Demirel University Faculty of Dentistry Pediatric Denti
Jul 16, 2022

Emotional Proactive Processing in Bipolar Disorder

Active, not recruiting
  • Bipolar Disorder
  • +2 more
  • Emotional Stroop Task
  • La Tronche, Isère, France
    CHU Grenoble Alpes
May 17, 2022

Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United

Active, not recruiting
  • Ann Arbor Stage IB Hodgkin Lymphoma
  • +10 more
  • Brentuximab Vedotin
  • Nivolumab
  • Palo Alto, California
  • +8 more
Jul 20, 2022

Multimorbidity Trial in Boston (Vital Moto Mod, Welch Allyn Connex Spot Vital Signs Monitor, Capnostream 20 Portable Bedside

Completed
  • Multimorbidity
  • Vital Moto Mod
  • +4 more
  • Boston, Massachusetts
    Partners Connected Health
Aug 29, 2020

Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

Not yet recruiting
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +21 more
  • Biopsy
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 7, 2023

Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +13 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 18, 2022

AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

Active, not recruiting
  • AIDS-Related Hodgkin Lymphoma
  • +11 more
  • Brentuximab Vedotin
  • +4 more
  • La Jolla, California
  • +27 more
Jul 27, 2022

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)

Recruiting
  • Safety Issues
  • Efficacy, Self
  • low dose nivolumab in combination with AVD
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr Jose Eleuterio Gonzalez
Mar 6, 2023

Investigate Contact Sensitization Using Classic and Machine

Recruiting
  • Allergic Contact Dermatitis
  • patch test for diagnosing allergic contact dermatitis
  • Athens, Attica, Greece
    Georgia Gogkla
Aug 7, 2023

Shock, Septic Trial in Maribor (Simultaneous administration of vasopressors, Successive administration of vasopressors)

Recruiting
  • Shock, Septic
  • Simultaneous administration of vasopressors
  • Successive administration of vasopressors
  • Maribor, Slovenia
    Medical intensive care unit UMC Maribor
Dec 2, 2023

Kaposi Sarcoma, Progression, Disease Trial in Paris (Pembrolizumab)

Unknown status
  • Kaposi Sarcoma
  • Progression, Disease
  • Paris, France
    Saint-Louis Hospital
Oct 18, 2019

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial in Houston (Bortezomib, Carboplatin, Etoposide)

Completed
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Apr 9, 2020

Hodgkin Lymphoma, Adult Trial in Beijing (SHR-1210)

Completed
  • Hodgkin Lymphoma, Adult
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 29, 2021

Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed Multiple Myeloma
  • Belantamab mafodotin
  • +2 more
  • Badalona, Spain
  • +14 more
Sep 5, 2022

Acute Coronary Syndrome Trial in Madrid (Multicomponent Psychological Program (MPP))

Completed
  • Acute Coronary Syndrome
  • Multicomponent Psychological Program (MPP)
  • Madrid, Spain
    Hospital Universitario 12 de Octubre
Mar 17, 2022

Facial Acne Vulgaris Trial in Assiut (retinyl palmitate, Tretinoin)

Completed
  • Facial Acne Vulgaris
  • Assiut, Egypt
    Assiut University Hospital
Nov 10, 2022

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023